Growth Metrics

Exelixis (EXEL) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Exelixis (EXEL) over the last 10 years, with Oct 2025 value amounting to $0.69.

  • Exelixis' EPS (Weighted Average and Diluted) rose 72.50% to $0.69 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.37, marking a year-over-year increase of 51.92%. This contributed to the annual value of $1.76 for FY2025, which is 170.77% up from last year.
  • As of Q4 2025, Exelixis' EPS (Weighted Average and Diluted) stood at $0.69, which was up 6.15% from $0.65 recorded in Q3 2025.
  • Exelixis' 5-year EPS (Weighted Average and Diluted) high stood at $0.77 for Q2 2024, and its period low was -$0.09 during Q4 2022.
  • Over the past 3 years, Exelixis' median EPS (Weighted Average and Diluted) value was $0.40 (recorded in 2024), while the average stood at $0.39.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first slumped by 130.49% in 2022, then soared by 12,360.21% in 2024.
  • Exelixis' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.30 in 2021, then tumbled by 130.49% to -$0.09 in 2022, then spiked by 400.00% to $0.27 in 2023, then surged by 12,360.21% to $0.40 in 2024, then soared by 72.50% to $0.69 in 2025.
  • Its last three reported values are $0.69 in Q4 2025, $0.65 for Q3 2025, and $0.55 during Q2 2025.